Related Experiment Video
Updated: Jul 9, 2026

A Traditional Chinese Medicine Characteristic Therapy for Bronchial Asthma: Moxibustion
Published on: May 12, 2023
Porphyrin and phthalocyanine antiscrapie compounds
S A Priola1, A Raines, W S Caughey
1Laboratory of Persistent Viral Diseases, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840, USA. spriola@nih.gov
New cyclic tetrapyrrole drugs show promise in treating transmissible spongiform encephalopathies (TSEs). These compounds significantly increased survival rates in infected animals, offering hope for a fatal neurodegenerative disease.
Area of Science:
- Neuroscience
- Pharmacology
- Biochemistry
Background:
- Transmissible spongiform encephalopathies (TSEs) are fatal neurodegenerative diseases with no current treatments.
- The potential for bovine TSEs to infect humans highlights the urgent need for effective anti-TSE drugs.
Purpose of the Study:
- To investigate the efficacy of cyclic tetrapyrroles as potential anti-TSE drugs.
- To determine if these compounds can inhibit PrP-res formation and improve survival in TSE-infected animals.
Main Methods:
- Treatment of TSE-infected animals with three different cyclic tetrapyrrole compounds.
- Monitoring of survival rates and assessment of PrP-res inhibition (in vitro data mentioned in abstract).
Main Results:
- Treatment with cyclic tetrapyrroles increased animal survival time by 50% to 300%.
- Structurally diverse tetrapyrroles demonstrated significant inhibition of TSE disease progression.
Conclusions:
- Cyclic tetrapyrroles are effective anti-TSE drugs.
- These compounds represent a promising therapeutic strategy for fatal neurodegenerative TSEs.
More Related Videos
12:34The Efficacy and Underlying Pathway Mechanisms of ShiDuGao Treatment for Anus Eczema Based on GEO Datasets and Network Pharmacology
Published on: January 12, 2024
08:44Elucidation of the Material Basis of Yiqi Qingjie Formula Against IgA Nephropathy Using UHPLC-Q-Orbitrap HRMS Integrated with Network Pharmacology
Published on: May 19, 2026
Related Concept Videos
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
Drugs for Treatment of Ulcerative Colitis in IBD
Antifungal Agents